Modulation of catecholamine release from rat striatal slices by the fixed combination of aspirin, paracetamol and caffeine

Pharmacological Research

Volumn 53, Issue 4, 2006, Pages 391-396

  Fiebich, Bernd L ^a,b   Candelario Jalil, Eduardo ^a   Mantovani, Michela ^c   Heinzmann, Marcus ^a,b   Akundi, Ravi Shankar ^a   Hüll, Michael ^a   Knörle, Rainer ^d   Schnierle, Peter ^d   Finkenzeller, Günter ^c   Aicher, Bernhard ^e  

^a UNIVERSITY OF FREIBURG   (Germany)

^b VIVACELL BIOTECHNOLOGY GMBH   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d Inst Biochemische Analysen M   (Germany)

^e BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Acetaminophen; Catecholamine; Combination analgesics; Dopamine; Nociception; Norepinephrine

Indexed keywords

APC; CATECHOLAMINE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN SLICE; CATECHOLAMINE RELEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; DRUG FORMULATION; DRUG POTENTIATION; INCUBATION TIME; MALE; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; STRIATE CORTEX;

ACETAMINOPHEN; ANIMALS; ASPIRIN; BRAIN; CAFFEINE; CORPUS STRIATUM; DOPAMINE; MALE; NOREPINEPHRINE; PAIN; RATS;

EID: 33646472028     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.02.002     Document Type: Article

References (45)

1. Aicher B., and Kraupp O. Effectiveness of fixed analgesic combinations exemplified by thomapyrin. Wien Klin Wochenschr 108 (1996) 219-233
2. Camann W.R., Murray R.S., Mushlin P.S., and Lambert D.H. Effects of oral caffeine on postdural puncture headache. A double-blind, placebo-controlled trial. Anesth Analg 70 (1990) 181-184
3. Ward N., Whitney C., Avery D., and Dunner D. The analgesic effects of caffeine in headache. Pain 44 (1991) 151-155
4. Yücel A., Özyalcin S., Talu G.K., Yücel E.C., and Erdine S. Intravenous administration of caffeine sodium benzoate for postdural puncture headache. Reg Anesth Pain Med 2 (1999) 51-54
5. Myers D.E., Shaikh Z., and Zullo T.G. Hypoalgesic effect of caffeine in experimental ischemic muscle contraction pain. Headache 37 (1997) 654-658
6. Laska E.M., Sunshine A., Zighelboim I., Roure C., Marrero I., Wanderling J., et al. Effect of caffeine on acetaminophen analgesia. Clin Pharmacol Ther 33 (1983) 498-509
7. Laska E.M., Sunshine A., Mueller F., Elvers W.B., Siegel C., and Rubin A. Caffeine as an analgesic adjuvant. JAMA 251 (1984) 1711-1718
8. Sawynok J., and Yaksh T.L. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol Rev 45 (1993) 43-85
9. Granados-Soto V., and Castaneda-Hernandez G. A review of the pharmacokinetic and pharmacodynamic factors in the potentiation of the antinociceptive effect of nonsteroidal anti-inflammatory drugs by caffeine. J Pharmacol Toxicol Methods 42 (1999) 67-72
10. Hersh E.V., Moore P.A., and Ross G.L. Over-the-counter analgesics and antipyretics: a critical assessment. Clin Ther 22 (2000) 500-548
11. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for ASA-like drugs. Nat New Biol 231 (1971) 232-235
12. Engelhardt G. Animal experimental studies on the question of the interaction of paracetamol and acetylsalicylic acid. Arzneimittelforschung 34 (1984) 992-1001
13. Fiebich B.L., Lieb K., Hull M., Aicher B., van Ryn J., Pairet M., et al. Effects of caffeine and paracetamol alone or in combination with acetylsalicylic acid on prostaglandin E(2) synthesis in rat microglial cells. Neuropharmacology 39 (2000) 2205-2213
14. Boutaud O., Aronoff D.M., Richardson J.H., Marnett L.J., and Oates J.A. Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases. Proc Natl Acad Sci USA 99 (2002) 7130-7135
15. Chandrasekharan N.V., Dai H., Roos K.L., Evanson N.K., Tomsik J., Elton T.S., et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 99 (2002) 13926-13931
16. Diener H.C., Pfaffenrath V., Pageler L., Peil H., and Aicher B. The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 25 (2005) 776-787
17. Silberstein S.D. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55 (2000) 754-762
18. Haag G., Evers S., May A., Neu I.S., Vivell W., and Ziegler A. Selbstmedikation bei Migräne und Kopfschmerz vom Spannungstyp-Evidenz-basierte Empfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft (DMKG). Nervenheilkunde 23 (2004) 415-430
19. Goldstein J., Silberstein S.D., Saper J.R., Elkind A.H., Smith T.R., Gallagher R.M., et al. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial. Headache 45 (2005) 973-982
20. Courade J.P., Caussade F., Martin K., Besse D., Delchambre C., Hanoun N., et al. Effects of acetaminophen on monoaminergic systems in the rat central nervous system. Naunyn Schmiedebergs Arch Pharmacol 364 (2001) 534-537
21. Solinas M., Ferré S., You Z.B., Karcz-Kubicha M., Popoli P., and Goldberg S.R. Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci 22 (2002) 6321-6324
22. Karcz-Kubicha M., Antoniou K., and Terasmaa A. Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsychopharmacology 28 (2003) 1281-1291
23. Quarta D., Ferre S., Solinas M., You Z.B., Hockemeyer J., Popoli P., et al. Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J Neurochem 88 (2004) 1151-1158
24. Kaasinen V., Aalto S., Nagren K., and Rinne J.O. Dopaminergic effects of caffeine in the human striatum and thalamus. Neuroreport 15 (2004) 281-285
25. Kiritsy-Roy J.A., Standish S.M., and Terry L.C. Dopamine D-1 and D-2 receptor antagonists potentiate analgesic and motor effects of morphine. Pharmacol Biochem Behav 32 (1989) 717-721
26. Fanciullacci M., Alessandri M., and Del Rosso A. Dopamine involvement in the migraine attack. Funct Neurol 15 Suppl. 3 (2000) 171-181
27. Dooley D.J., Mieske C.A., and Borosky S.A. Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci Lett 280 (2000) 107-110
28. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83 (1977) 346-356
29. Holmberg M., Scheinin M., Kurose H., and Miettinen R. Adrenergic alpha2C-receptors reside in rat striatal GABAergic projection neurons: comparison of radioligand binding and immunohistochemistry. Neuroscience 93 (1999) 1323-1333
30. Holmberg M., Fagerholm V., and Scheinin M. Regional distribution of alpha(2C)-adrenoceptors in brain and spinal cord of control mice and transgenic mice overexpressing the alpha(2C)-subtype: an autoradiographic study with [(3)H]RX821002 and [(3)H]rauwolscine. Neuroscience 117 (2003) 875-898
31. Rosa-Neto P., Doudet D.J., and Cumming P. Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET. Neuroimage 22 (2004) 1076-1083
32. 14C]methyl-para-tyrosine in the rat. Synapse 17 (1994) 125-128
33. Cosford R.J., Vinson A.P., Kukoyi S., and Justice Jr. J.B. Quantitative microdialysis of serotonin and norepinephrine: pharmacological influences on in vivo extraction fraction. J Neurosci Methods 68 (1996) 39-47
34. Tunbridge E.M., Bannerman D.M., Sharp T., and Harrison P.J. Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci 24 (2004) 5331-5335
35. Liu Q.S., Qiao J.T., and Dafny N. D2 dopamine receptor involvement in spinal dopamine-produced antinociception. Life Sci 51 (1992) 1485-1492
36. Sagen J., and Proudfit H.K. Evidence for pain modulation by pre- and postsynaptic noradrenergic receptors in the medulla oblongata. Brain Res 331 (1985) 285-293
37. Silberstein S.D., Armellino J.J., Hoffman H.D., Battikha J.P., Hamelsky S.W., Stewart W.F., et al. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, ASA, and caffeine: results from three randomized, placebo-controlled studies. Clin Ther 21 (1999) 475-491
38. Goldstein J., Hoffman H.D., Armellino J.J., Battikha J.P., Hamelsky S.W., Couch J., et al. Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, ASA, and caffeine. Cephalalgia 19 (1999) 684-691
39. Diamond S. Caffeine as an analgesic adjuvant in the treatment of headache. Headache Q: Curr Treat Res 10 (1999) 119-125
40. Lipton R.B., Stewart W.F., Ryan Jr. R.E., Saper J., Silberstein S., and Sheftell F. Efficacy and safety of acetaminophen, ASA, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials. Arch Neurol 55 (1998) 210-217
41. Proudfit H.K. Pharmacologic evidence for the modulation of nociception by noradrenergic neurons. Prog Brain Res 77 (1988) 357-370
42. Mochizucki D. Serotonin and noradrenaline reuptake inhibitors in animal models of pain. Hum Psychopharmacol 19 Suppl. 1 (2004) S15-S19
43. Jasmin L., Tien D., Janni G., and Ohara P.T. Is noradrenaline a significant factor in the analgesic effect of antidepressants?. Pain 106 (2003) 3-8
44. Coquoz D., Porchet H.C., and Dayer P. Central analgesic effects of desipramine, fluvoxamine, and moclobemide after single oral dosing: a study in healthy volunteers. Clin Pharmacol Ther 54 (1993) 339-344
45. Dello Russo C., Boullerne A.I., Gavrilyuk V., and Feinstein D.L. Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production. J Neuroinflammation 1 (2004) 9